MABC613MI

MilliporeSigma™ Mouse anti-B7-H6, Clone: 5.51.18,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 MABC613MI-Each-of-1 In Stock ₹ 44,393.20

MABC613MI - Each of 1

₹ 44,393.20

In Stock

Quantity

1

Base Price: ₹ 44,393.20

GST (18%): ₹ 7,990.776

Total Price: ₹ 52,383.976

Antigen

B7-H6

Classification

Monoclonal

Formulation

Purified mouse monoclonal IgG1κ in buffer containing 0.1M Tris-Glycine (pH 7.4), 150mM NaCl with 0.05% sodium azide.

Gene Symbols

NCR3LG1; B7H6

Immunogen

Recombinant protein corresponding to the extracellular domain of human B7-H6.

Quantity

100 μg

Research Discipline

Apoptosis, Cancer

Gene ID (Entrez)

NP_001189368

Content And Storage

Stable for one year at 2°C to 8°C from date of receipt.

Isotype

IgG1 κ

Applications

Flow Cytometry

Clone

5.51.18

Gene Accession No.

Q68D85

Host Species

Mouse

Purification Method

Protein G Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human

Form

Purified

Related Products

Img

MilliporeSigma™

MABC527MI

--

Img

MilliporeSigma™

MABC550MI

--

Img

MilliporeSigma™

MABC565MI

--

Img

MilliporeSigma™

MABC269MI

--

Img

MilliporeSigma™

MABT324MI

--

Img

MilliporeSigma™

MABC563MI

--

Img

MilliporeSigma™

MABT388MI

--

Img

MilliporeSigma™

MABS485MI

--

Description

  • Specifically detects B7-H6 clone: 5.51.18 in Human samples, and it is validated for Flow Cytometry B7-H6 (also known as B7 homolog 6 or Natural cytotoxicity triggering receptor 3 ligand 1) is a single-pass membrane protein encoded by the NCR3LG1 or B7H6 gene (Entrez Gene ID 374383) in human
  • B7-H6 belongs to the B7 family of structurally related cell-surface ligands, which bind to receptors on lymphocytes that regulate immune responses
  • The natural cytotoxicity receptor NCR3/NKp30 is involved in NK-cell–mediated killing of various tumor cell lines
  • B7-H6 is identified as the NKp30 ligand on cancer cells, while normal tissues were reported to lack B7-H6 transcripts
  • Decreased NKp30 expression is reported to correlate with poor prognosis and survival among patients with acute myeloid leukemia (AML)
  • Class I histone deacetylases HDAC2 & HDAC3 are reported to be involved in B7-H6 transcription activation, and HDAC inhibitors are found to impair tumor cell recognition by NK cells
  • This monoclonal antibody is suitable for flow cytometric analysis, but does not compete against NKp30 binding (PMID 23801635).